Bristol-Myers is buying Calgene, which means that we are looking at major consolidation layoffs very soon.
You can expect plenty of cuts and layoffs with this move. Bristol-Myers is laying out its expectations for finding $2.5 billion in annual cost reductions by 2022 as it merges the two operations.
https://endpts.com/bristol-myers-inks-a-74b-deal-to-buy-out-celgene-expects-15b-a-year-from-late-stage-pipeline/
Good luck all!